Use of a Treatment Benefit Questionnaire in Patients With Chronic Migraine Treated With OnabotulinumtoxinA (BOTOX)
Phase of Trial: Phase IV
Latest Information Update: 23 Oct 2015
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Allergan
- 29 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jun 2014 Planned End Date changed from 1 Dec 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.
- 05 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.